Approximately 30% of Waldenstrom macroglobulinemia patients are advised to "watch and wait" at time of diagnosis. When should a patient seek treatment?

Dr. Steven Treon, Director from the Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute joins Patient Power co-founder Andrew Schorr to explain the signs and symptoms that indicate it is time for a patient and doctor to discuss treatment. To learn more, watch the discussion by clicking the link below: